Mechanistic Insights Into the Tumor-Driving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In Vitro Analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Potassium Channel Tetramerization Domain-containing (KCTD) genes show altered expression in ovarian cancer (OC). Some KCTD genes act as tumor suppressors, indicating their potential as diagnostic and therapeutic biomarkers for OC.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Ovarian cancer (OC) is a leading cause of gynecological cancer mortality.
- Late diagnosis and high recurrence rates contribute to poor patient survival.
- There is a critical need for novel biomarkers for early detection and prognosis in OC.
Purpose Of The Study
- To investigate the role of Potassium Channel Tetramerization Domain-containing (KCTD) genes in ovarian cancer.
- To identify potential KCTD biomarkers for OC diagnosis and prognosis.
Main Methods
- Comprehensive in silico and in vitro experimental analyses were performed.
- RT-qPCR was used to analyze KCTD gene expression in OC cell lines and normal controls.
- Functional assays, ROC analysis, and immune/drug sensitivity analyses were conducted.
Main Results
- Significant differential expression of KCTD genes (upregulation and downregulation) was observed in OC cell lines.
- KCTD2, KCTD5, KCTD9, and KCTD12 demonstrated high diagnostic accuracy.
- Overexpression of KCTD2 and KCTD10 inhibited OC cell proliferation and migration, suggesting tumor-suppressive functions.
Conclusions
- KCTD family members show promise as diagnostic and prognostic biomarkers for ovarian cancer.
- These findings offer new insights into therapeutic strategies for OC.
- Further clinical validation is required to establish KCTD genes as therapeutic targets.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
The Process
Genes can be randomly knocked out, or specific genes can be targeted. To knock out a particular gene, an engineered piece of DNA called a targeting vector is used...